世界の生体防御市場予測(~2025年)

• 英文タイトル:Global Biodefense Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Biodefense Market 2020 by Company, Regions, Type and Application, Forecast to 2025「世界の生体防御市場予測(~2025年)」(市場規模、市場予測)調査レポートです。• レポートコード:GIR201113693
• 出版社/出版日:GlobalInfoResearch / 2020年10月
• レポート形態:英文、PDF、124ページ
• 納品方法:Eメール
• 産業分類:新技術
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、生体防御の世界市場を調査対象にし、生体防御の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(炭疽、天然痘、ボツリヌス中毒、放射線/核、その他)、用途別分析(米国軍事市場、米国民間市場、米国以外市場)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Emergent Biosolutions、Arbutus Biopharma、Sanofi、Hytest、SIGA Technologies、GSK、Xoma Corporation、Bavarian Nordic、PharmAthene、DynPort Vaccine、Dynavax Technologies、Alnylam Pharmaceuticals、Ichor Medical Systems、Cleveland BioLabs、Elusys Therapeutics、Aeolus Pharmaceuticals、Soligenix、Achaogen
・企業別売上、市場シェア
・生体防御の地域別市場分析
・生体防御の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・生体防御のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・生体防御のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・生体防御の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・生体防御の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・生体防御の種類別市場規模2015-2020:炭疽、天然痘、ボツリヌス中毒、放射線/核、その他
・生体防御の用途別市場規模2015-2020:米国軍事市場、米国民間市場、米国以外市場
・生体防御の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The Biodefense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Biodefense market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 1332.3 million by 2025, from USD 1016.9 million in 2019.

Market segmentation
Biodefense market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biodefense market has been segmented into:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

By Application, Biodefense has been segmented into:
US Military Market
US Civilian Market
Non – US Market

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biodefense market presented in the report. This section sheds light on the sales growth of different regional and country-level Biodefense markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biodefense market.

The report offers in-depth assessment of the growth and other aspects of the Biodefense market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Biodefense Market Share Analysis
Biodefense competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biodefense sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biodefense sales, revenue and market share for each player covered in this report.

The major players covered in Biodefense are:
Emergent Biosolutions
Arbutus Biopharma
Sanofi
Hytest
SIGA Technologies
GSK
Xoma Corporation
Bavarian Nordic
PharmAthene
DynPort Vaccine
Dynavax Technologies
Alnylam Pharmaceuticals
Ichor Medical Systems
Cleveland BioLabs
Elusys Therapeutics
Aeolus Pharmaceuticals
Soligenix
Achaogen
Among other players domestic and global, Biodefense market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Biodefense Market Overview
1.1 Product Overview and Scope of Biodefense
1.2 Classification of Biodefense by Type
1.2.1 Global Biodefense Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biodefense Revenue Market Share by Type in 2019
1.2.3 Anthrax
1.2.4 Smallpox
1.2.5 Botulism
1.2.6 Radiation/Nuclear
1.2.7 Others
1.3 Global Biodefense Market by Application
1.3.1 Overview: Global Biodefense Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non – US Market
1.4 Global Biodefense Market by Regions
1.4.1 Global Biodefense Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biodefense (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biodefense Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biodefense Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biodefense Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biodefense Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biodefense Status and Prospect (2015-2025)
2 Company Profiles
2.1 Emergent Biosolutions
2.1.1 Emergent Biosolutions Details
2.1.2 Emergent Biosolutions Major Business
2.1.3 Emergent Biosolutions SWOT Analysis
2.1.4 Emergent Biosolutions Product and Services
2.1.5 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arbutus Biopharma
2.2.1 Arbutus Biopharma Details
2.2.2 Arbutus Biopharma Major Business
2.2.3 Arbutus Biopharma SWOT Analysis
2.2.4 Arbutus Biopharma Product and Services
2.2.5 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hytest
2.4.1 Hytest Details
2.4.2 Hytest Major Business
2.4.3 Hytest SWOT Analysis
2.4.4 Hytest Product and Services
2.4.5 Hytest Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.5 SIGA Technologies
2.5.1 SIGA Technologies Details
2.5.2 SIGA Technologies Major Business
2.5.3 SIGA Technologies SWOT Analysis
2.5.4 SIGA Technologies Product and Services
2.5.5 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Product and Services
2.6.4 GSK Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.7 Xoma Corporation
2.7.1 Xoma Corporation Details
2.7.2 Xoma Corporation Major Business
2.7.3 Xoma Corporation Product and Services
2.7.4 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business
2.8.3 Bavarian Nordic Product and Services
2.8.4 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.9 PharmAthene
2.9.1 PharmAthene Details
2.9.2 PharmAthene Major Business
2.9.3 PharmAthene Product and Services
2.9.4 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.10 DynPort Vaccine
2.10.1 DynPort Vaccine Details
2.10.2 DynPort Vaccine Major Business
2.10.3 DynPort Vaccine Product and Services
2.10.4 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.11 Dynavax Technologies
2.11.1 Dynavax Technologies Details
2.11.2 Dynavax Technologies Major Business
2.11.3 Dynavax Technologies Product and Services
2.11.4 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.12 Alnylam Pharmaceuticals
2.12.1 Alnylam Pharmaceuticals Details
2.12.2 Alnylam Pharmaceuticals Major Business
2.12.3 Alnylam Pharmaceuticals Product and Services
2.12.4 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ichor Medical Systems
2.13.1 Ichor Medical Systems Details
2.13.2 Ichor Medical Systems Major Business
2.13.3 Ichor Medical Systems Product and Services
2.13.4 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cleveland BioLabs
2.14.1 Cleveland BioLabs Details
2.14.2 Cleveland BioLabs Major Business
2.14.3 Cleveland BioLabs Product and Services
2.14.4 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.15 Elusys Therapeutics
2.15.1 Elusys Therapeutics Details
2.15.2 Elusys Therapeutics Major Business
2.15.3 Elusys Therapeutics Product and Services
2.15.4 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aeolus Pharmaceuticals
2.16.1 Aeolus Pharmaceuticals Details
2.16.2 Aeolus Pharmaceuticals Major Business
2.16.3 Aeolus Pharmaceuticals Product and Services
2.16.4 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.17 Soligenix
2.17.1 Soligenix Details
2.17.2 Soligenix Major Business
2.17.3 Soligenix Product and Services
2.17.4 Soligenix Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.18 Achaogen
2.18.1 Achaogen Details
2.18.2 Achaogen Major Business
2.18.3 Achaogen Product and Services
2.18.3 Achaogen Biodefense Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biodefense Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biodefense Players Market Share
3.2.2 Top 10 Biodefense Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biodefense Revenue and Market Share by Regions
4.2 North America Biodefense Revenue and Growth Rate (2015-2020)
4.3 Europe Biodefense Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biodefense Revenue and Growth Rate (2015-2020)
4.5 South America Biodefense Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biodefense Revenue and Growth Rate (2015-2020)
5 North America Biodefense Revenue by Countries
5.1 North America Biodefense Revenue by Countries (2015-2020)
5.2 USA Biodefense Revenue and Growth Rate (2015-2020)
5.3 Canada Biodefense Revenue and Growth Rate (2015-2020)
5.4 Mexico Biodefense Revenue and Growth Rate (2015-2020)
6 Europe Biodefense Revenue by Countries
6.1 Europe Biodefense Revenue by Countries (2015-2020)
6.2 Germany Biodefense Revenue and Growth Rate (2015-2020)
6.3 UK Biodefense Revenue and Growth Rate (2015-2020)
6.4 France Biodefense Revenue and Growth Rate (2015-2020)
6.5 Russia Biodefense Revenue and Growth Rate (2015-2020)
6.6 Italy Biodefense Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biodefense Revenue by Countries
7.1 Asia-Pacific Biodefense Revenue by Countries (2015-2020)
7.2 China Biodefense Revenue and Growth Rate (2015-2020)
7.3 Japan Biodefense Revenue and Growth Rate (2015-2020)
7.4 Korea Biodefense Revenue and Growth Rate (2015-2020)
7.5 India Biodefense Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biodefense Revenue and Growth Rate (2015-2020)
8 South America Biodefense Revenue by Countries
8.1 South America Biodefense Revenue by Countries (2015-2020)
8.2 Brazil Biodefense Revenue and Growth Rate (2015-2020)
8.3 Argentina Biodefense Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biodefense by Countries
9.1 Middle East & Africa Biodefense Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biodefense Revenue and Growth Rate (2015-2020)
9.3 UAE Biodefense Revenue and Growth Rate (2015-2020)
9.4 Egypt Biodefense Revenue and Growth Rate (2015-2020)
9.5 South Africa Biodefense Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biodefense Revenue and Market Share by Type (2015-2020)
10.2 Global Biodefense Market Forecast by Type (2019-2024)
10.3 Anthrax Revenue Growth Rate (2015-2025)
10.4 Smallpox Revenue Growth Rate (2015-2025)
10.5 Botulism Revenue Growth Rate (2015-2025)
10.6 Radiation/Nuclear Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Biodefense Market Segment by Application
11.1 Global Biodefense Revenue Market Share by Application (2015-2020)
11.2 Biodefense Market Forecast by Application (2019-2024)
11.3 US Military Market Revenue Growth (2015-2020)
11.4 US Civilian Market Revenue Growth (2015-2020)
11.5 Non – US Market Revenue Growth (2015-2020)
12 Global Biodefense Market Size Forecast (2021-2025)
12.1 Global Biodefense Market Size Forecast (2021-2025)
12.2 Global Biodefense Market Forecast by Regions (2021-2025)
12.3 North America Biodefense Revenue Market Forecast (2021-2025)
12.4 Europe Biodefense Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biodefense Revenue Market Forecast (2021-2025)
12.6 South America Biodefense Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biodefense Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US




• 英文レポート名:Global Biodefense Market 2020 by Company, Regions, Type and Application, Forecast to 2025
• 日本語訳:世界の生体防御市場予測(~2025年)
• レポートコード:GIR201113693お問い合わせ(見積依頼・ご注文・質問)